Kenya vs Yemen: Treatment coverage for schistosomiasis
Kenya
84.6%
in 2024
Yemen
78.7%
in 2022
Kenya rank
7th
Yemen rank
9th
Treatment coverage for schistosomiasis over time
- Kenya
- Yemen
How they compare
Kenya currently reports 84.6% against 78.7% in Yemen, a difference of 5.9%.
That makes Kenya's figure about 1.1 times Yemen's.
The two have swapped places 1 time across 8 shared years of data; in 2013 it was Yemen ahead.
Kenya ranks 7th and Yemen ranks 9th of 45 countries.
Across the 2 decades both report, Kenya averaged higher in 1 and Yemen in 1.
Head to head by decade
| Decade | Kenya | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 20.5% | 73.8% | 53.3% | Yemen |
| 2020s | 79.8% | 67.6% | 12.1% | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Kenya or Yemen?
- Kenya, at 84.6% against 78.7% in Yemen as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Kenya and Yemen?
- 5.9%, with Kenya ahead.
- How many years of comparable data are there for Kenya and Yemen?
- 8 years are reported by both, from 2013 to 2022.
- How do Kenya and Yemen rank globally for treatment coverage for schistosomiasis?
- Kenya ranks 7th and Yemen ranks 9th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) β with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.